公开(公告)号：US20160264668A1

公开(公告)日：2016-09-15

申请号：US15036209

申请日：2014-11-12

Applicant: UCB BIOPHARMA SPRL

Inventor： Paul Alan ATHERFOLD ,  Thomas Allen CESKA ,  Helene Margaret FINNEY ,  Lara KEVORKIAN ,  Kaushik SARKAR ,  Bryan John SMITH ,  Kerry Louise TYSON

IPC: C07K16/28 ,  A61K47/48

CPC classification number: C07K16/283 ,  A61K47/60 ,  A61K47/6849 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/55 ,  C07K2317/565 ,  C07K2317/624 ,  C07K2317/76 ,  C07K2317/92 ,  C07K2317/94

Abstract: The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.

Abstract translation: 本公开涉及对FcRn特异性的抗体，包含其的制剂，治疗中的每一种的使用，用于表达和任选配制所述抗体的方法，编码抗体的DNA和包含所述DNA的宿主。

公开(公告)号：US20190270811A1

公开(公告)日：2019-09-05

申请号：US16299407

申请日：2019-03-12

Applicant: UCB BIOPHARMA SPRL

Inventor： Paul Alan ATHERFOLD ,  Thomas Allen CESKA ,  Helene Margaret FINNEY ,  Lara KEVORKIAN ,  Kaushik SARKAR ,  Bryan John SMITH ,  Kerry Louise TYSON

IPC: C07K16/28 ,  A61K47/68 ,  A61K47/60

Abstract: The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.

公开(公告)号：US20220162311A1

公开(公告)日：2022-05-26

申请号：US17643506

申请日：2021-12-09

Applicant: UCB BIOPHARMA SPRL

Inventor： Paul Alan ATHERFOLD ,  Thomas Allen CESKA ,  Helene Margaret FINNEY ,  Lara KEVORKIAN ,  Kaushik SARKAR ,  Bryan John SMITH ,  Kerry Louise TYSON

IPC: C07K16/28 ,  A61K47/68 ,  A61K47/60

Abstract: The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.